|
Equivalence Test for 2x2 Crossover DesignEffects |
The Effects table shows the analysis for the following possible effects:
Note |
You should not evaluate equivalence if either the carryover effect or the period effect is significant. If either effect is significant, then the equivalence results may be unreliable. |
Example Output |
Effect SE DF T-Value P-Value 95% CI Carryover 0.45181 0.64988 15 0.69521 0.498 (-0.93339, 1.8370) Treatment -0.32104 0.060641 15 -5.2941 0.000 (-0.45030, -0.19179) Period -0.097708 0.060641 15 -1.6112 0.128 (-0.22696, 0.031546) |
Interpretation |
For the antacid data, the p-value for the carryover effect (0.498) and the p-value for the period effect (0.128) are both greater than 0.05. Thus these effects are not significant at the 0.05 level.
The p-value for the treatment effect (0.000) is less than 0.05. Thus the treatment effect is significant at the 0.05 level. The significant treatment effect indicates that one antacid is better than the other at raising stomach pH. However, a significant treatment effect does not mean that you cannot claim equivalence. The difference between the treatment means may still be within your equivalence limits.